Making Progress on Progression in Metastatic Prostate Cancer

被引：3
作者：
Armstrong, Andrew J. [1 ]
Halabi, Susan [2 ]
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC 27708 USA
[2] Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 12期
关键词：
END-POINTS; CLINICAL-TRIALS; FREE SURVIVAL; MEN; IMMUNOTHERAPY; MITOXANTRONE; ABIRATERONE; PREDNISONE; SURROGACY; ANTIGEN;
D O I：
10.1200/JCO.2014.59.4283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1322 / U17
页数：4
相关论文
共 21 条
[1]   Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer [J].
Armstrong, Andrew J. ;
Garrett-Mayer, Elizabeth ;
Yang, Yi-Chun Ou ;
Carducci, Michael A. ;
Tannock, Ian ;
de Wit, Ronald ;
Eisenberger, Mario .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) :3965-3970
[2]   Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC) [J].
Armstrong, Andrew J. ;
Kaboteh, Reza ;
Carducci, Michael A. ;
Damber, Jan-Erik ;
Stadler, Walter M. ;
Hansen, Mats ;
Edenbrandt, Lars ;
Forsberg, Goran ;
Nord, Orjan ;
Pili, Roberto ;
Morris, Michael J. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (08) :1308-1316
[3]   Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer [J].
Armstrong, Andrew J. ;
Eisenberger, Mario A. ;
Halabi, Susan ;
Oudard, Stephane ;
Nanus, David M. ;
Petrylak, Daniel P. ;
Sartor, A. Oliver ;
Scher, Howard I. .
EUROPEAN UROLOGY, 2012, 61 (03) :549-559
[4]   Enzalutamide in Metastatic Prostate Cancer before Chemotherapy [J].
Froehner, Michael ;
Wirth, Manfred P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (18) :1755-1755
[5]   Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial [J].
de Bono, Johann Sebastian ;
Oudard, Stephane ;
Ozguroglu, Mustafa ;
Hansen, Steinbjorn ;
Machiels, Jean-Pascal ;
Kocak, Ivo ;
Gravis, Gwenaelle ;
Bodrogi, Istvan ;
Mackenzie, Mary J. ;
Shen, Liji ;
Roessner, Martin ;
Gupta, Sunil ;
Sartor, A. Oliver .
LANCET, 2010, 376 (9747) :1147-1154
[6]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[7]   Pain predicts overall survival in men with metastatic castration-refractory prostate cancer [J].
Halabi, Susan ;
Vogelzang, Nicholas J. ;
Kornblith, Alice B. ;
Ou, San-San ;
Kantoff, Philip W. ;
Dawson, Nancy A. ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2544-2549
[8]   Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy [J].
Halabi, Susan ;
Armstrong, Andrew J. ;
Sartor, Oliver ;
de Bono, Johann ;
Kaplan, Ellen ;
Lin, Chen-Yen ;
Solomon, Nicole C. ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (31) :3944-+
[9]   Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer [J].
Halabi, Susan ;
Vogelzang, Nicholas J. ;
Ou, San-San ;
Owzar, Kouros ;
Archer, Laura ;
Small, Eric J. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) :2766-2771
[10]   Improved Endpoints for Cancer Immunotherapy Trials [J].
Hoos, Axel ;
Eggermont, Alexander M. M. ;
Janetzki, Sylvia ;
Hodi, F. Stephen ;
Ibrahim, Ramy ;
Anderson, Aparna ;
Humphrey, Rachel ;
Blumenstein, Brent ;
Old, Lloyd ;
Wolchok, Jedd .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (18) :1388-1397
123